Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology
Year: 2016
Type: article
Abstract: We examined the relationship of diabetes and hemoglobin A1C (A1C) to 2 common causes of dementia. The study included 1228 subjects who underwent annual clinical evaluations and a brain autopsy at death, as part of a Rush longitudinal cohort study of aging. A total of 433 subjects had A1C data available. Neuropathologic evaluations documented the size and location of infarcts. Modified silver stain-based Alzheimer disease (AD) measures included global and regional scores. We used regression analyses to examine associations of diabetes and A1C with overall and regional neuropathology. Diabetes [odds ratio (OR)=0.94; 95% confidence interval (CI), 0.73-1.20) and A1C (OR=0.83; 95% CI, 0.62-1.10) were not associated with global AD pathology across the brain, nor with overall or individual measures of neuropathology in mesial temporal or neocortical regions separately (all P>0.05). Diabetes was associated with a higher odds of any infarct (OR=1.43; 95% CI, 1.07-1.90), and particularly with gross (OR=1.53; 95% CI, 1.14-2.06) but not microinfarcts (P=0.06), and subcortical (OR=1.79; 95% CI, 1.34-2.39) but not cortical infarcts (P=0.83). In summary, we found no relationship of diabetes or A1C with global or regional AD pathology, including in the mesial temporal lobe. Diabetes is associated with gross subcortical infarcts. Our results suggest that the diabetes-dementia link is based on subcortical vascular pathology and not on regional AD pathology.
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Epidemiologic Study of Neural Reserve and Neurobiology of Aging, Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia., Mechanisms linking insulin resistance to brain structure, pathology, and function, Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease, Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia., Risk Factors, Pathology, and Clinical Expressions of AD, Rush Alzheimer's Disease Core Center, Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia, Vascular Cognitive and Motor Decline: Impact of aPL, Risk Factors, Pathology, and Clinical Expressions of AD, Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease
OpenAlex ID: W2534903119
